Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting β-Catenin Degradation in Type 1 Diabetic Mice
Xiaoqing Chen(Guangzhou Medical University), Ning Hou(Union Hospital), Xun Yuan(Guizhou Forestry Science Research Institute), Xiaoxia Qiu(Zhujiang Hospital), Yuan Qin(Zhejiang Sci-Tech University), Guiping Zhang(Guangzhou Medical University), Xia-Wen Liu(State Key Laboratory of Respiratory Disease), Conglin Li(Guangzhou Medical University), Yue Zeng(Shandong University), Cheng-Feng Luo(State Key Laboratory of Respiratory Disease), Jiandong Luo(Hangzhou Red Cross Hospital), Yuling Lian(Guangzhou Medical University), Wenchang Yuan(Guangzhou Medical University), Yilang Li(Sun Yat-sen University)
Cited by 16
Related Papers
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
|Clinical Epigenetics|2021|253
BMP4 Signaling Acts via Dual-Specificity Phosphatase 9 to Control ERK Activity in Mouse Embryonic Stem Cells
|Cell stem cell|2012|162
Targeted Disruption of <i>Smad4</i> in Cardiomyocytes Results in Cardiac Hypertrophy and Heart Failure
|Circulation Research|2005|140